GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Cyclically Adjusted PB Ratio

Purple Biotech (XTAE:PPBT) Cyclically Adjusted PB Ratio : 0.04 (As of Jun. 11, 2024)


View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Cyclically Adjusted PB Ratio?

As of today (2024-06-11), Purple Biotech's current share price is ₪0.206. Purple Biotech's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was ₪5.07. Purple Biotech's Cyclically Adjusted PB Ratio for today is 0.04.

The historical rank and industry rank for Purple Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

XTAE:PPBT' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.06
Current: 0.04

During the past 11 years, Purple Biotech's highest Cyclically Adjusted PB Ratio was 0.06. The lowest was 0.00. And the median was 0.00.

XTAE:PPBT's Cyclically Adjusted PB Ratio is ranked better than
93.8% of 661 companies
in the Biotechnology industry
Industry Median: 1.67 vs XTAE:PPBT: 0.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Purple Biotech's adjusted book value per share data of for the fiscal year that ended in Dec23 was ₪0.504. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₪5.07 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Purple Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Purple Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Cyclically Adjusted PB Ratio Chart

Purple Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.06

Purple Biotech Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.06 -

Competitive Comparison of Purple Biotech's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Purple Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Purple Biotech's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Purple Biotech's Cyclically Adjusted PB Ratio falls into.



Purple Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Purple Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.206/5.07
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Purple Biotech's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Purple Biotech's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=0.504/129.4194*129.4194
=0.504

Current CPI (Dec23) = 129.4194.

Purple Biotech Annual Data

Book Value per Share CPI Adj_Book
201412 12.835 99.070 16.767
201512 9.020 99.792 11.698
201612 6.497 101.863 8.255
201712 2.455 104.011 3.055
201812 2.445 105.998 2.985
201912 1.981 108.420 2.365
202012 1.716 109.897 2.021
202112 1.355 117.630 1.491
202212 0.944 125.222 0.976
202312 0.504 129.419 0.504

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Purple Biotech  (XTAE:PPBT) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Purple Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Purple Biotech (XTAE:PPBT) Business Description

Traded in Other Exchanges
Address
4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.